logo
Sign in

DXCM Stock Price, Chart, Stats & News

DexCom, Inc.
Save
26.59B
Market cap
29.58x
Current P/E
28.33x
Forward P/E

DXCM chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
60.10%
Operating margin
19.56%
Pretax margin
23.35%
Net margin
17.94%
Effective tax rate
23.16%
ROA
13.19%
ROE
32.44%
D/E
0.51x
Interest coverage ratio
64.67x

DXCM valuation

P/E
29.58x
P/S
5.21x
P/B
8.77x
P/CF
16.71x
P/FCF
22.54x
P/OCF
16.71x
PEG
1.78x
EV multiple
17.81x

About

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform.

Similar securities

Based on sector and market capitalization

Report issue